Research Article
Hepatoma-Targeted Radionuclide Immune Albumin Nanospheres: 131I-antiAFPMcAb-GCV-BSA-NPs
Figure 3
Uptake curves of 131I and 131I-antiAFP-GCV-BSA-NPs in HepG2 cells and HEK293 cells. The intake ratios of 131I-antiAFPMcAb-GCV-BSA-NPs in HepG2 cells group are far higher than those of 131I in HepG2 cells group, 131I-antiAFPMcAb-GCV-BSA-NPs in HEK293 cells group, and 131I in HEK293 cells group.